Beaumont Financial Advisors LLC purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 3,367 shares of the company's stock, valued at approximately $304,000.
A number of other institutional investors have also recently made changes to their positions in the stock. Hoey Investments Inc. increased its holdings in shares of Astera Labs by 4.2% in the 1st quarter. Hoey Investments Inc. now owns 5,000 shares of the company's stock worth $298,000 after buying an additional 200 shares during the last quarter. Sound Income Strategies LLC increased its holdings in shares of Astera Labs by 34.7% in the 1st quarter. Sound Income Strategies LLC now owns 792 shares of the company's stock worth $47,000 after buying an additional 204 shares during the last quarter. Allworth Financial LP increased its holdings in shares of Astera Labs by 20.4% in the 1st quarter. Allworth Financial LP now owns 1,394 shares of the company's stock worth $90,000 after buying an additional 236 shares during the last quarter. GAMMA Investing LLC increased its holdings in shares of Astera Labs by 55.7% in the 1st quarter. GAMMA Investing LLC now owns 794 shares of the company's stock worth $47,000 after buying an additional 284 shares during the last quarter. Finally, Wealthcare Advisory Partners LLC increased its holdings in shares of Astera Labs by 1.1% in the 1st quarter. Wealthcare Advisory Partners LLC now owns 28,939 shares of the company's stock worth $1,727,000 after buying an additional 320 shares during the last quarter. Institutional investors own 60.47% of the company's stock.
Wall Street Analyst Weigh In
A number of equities analysts have recently commented on the stock. Susquehanna increased their price target on shares of Astera Labs from $80.00 to $125.00 and gave the stock a "neutral" rating in a report on Thursday, August 7th. Deutsche Bank Aktiengesellschaft increased their target price on shares of Astera Labs from $160.00 to $200.00 and gave the company a "buy" rating in a report on Tuesday, September 2nd. Stifel Nicolaus set a $145.00 target price on shares of Astera Labs and gave the company a "buy" rating in a report on Monday, August 4th. Evercore ISI increased their target price on shares of Astera Labs from $104.00 to $215.00 and gave the company an "outperform" rating in a report on Wednesday, August 6th. Finally, Citigroup increased their target price on shares of Astera Labs from $160.00 to $275.00 and gave the company a "buy" rating in a report on Wednesday, September 17th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, Astera Labs has an average rating of "Moderate Buy" and an average price target of $152.94.
View Our Latest Stock Report on Astera Labs
Astera Labs Stock Down 1.4%
Shares of ALAB opened at $197.78 on Friday. The stock has a market capitalization of $32.87 billion, a P/E ratio of 353.18, a PEG ratio of 5.09 and a beta of 1.48. The firm has a fifty day simple moving average of $181.88 and a two-hundred day simple moving average of $114.65. Astera Labs, Inc. has a twelve month low of $47.13 and a twelve month high of $262.90.
Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.33 by $0.11. The business had revenue of $191.93 million during the quarter, compared to analysts' expectations of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The firm's revenue for the quarter was up 149.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Sell-side analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.
Insider Buying and Selling at Astera Labs
In other Astera Labs news, COO Sanjay Gajendra sold 91,441 shares of the stock in a transaction on Monday, August 18th. The shares were sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the completion of the sale, the chief operating officer owned 2,170,877 shares of the company's stock, valued at $398,377,638.27. This represents a 4.04% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, General Counsel Philip Mazzara sold 10,000 shares of the stock in a transaction on Thursday, August 28th. The shares were sold at an average price of $188.70, for a total transaction of $1,887,000.00. Following the sale, the general counsel directly owned 161,573 shares of the company's stock, valued at $30,488,825.10. The trade was a 5.83% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,576,027 shares of company stock worth $239,177,011 over the last ninety days. 12.50% of the stock is owned by company insiders.
About Astera Labs
(
Free Report)
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.